Authors:
JOHNSON CS
HERSHBERGER PA
MODZELEWSKI RA
YU WD
TRUMP DL
Citation: Cs. Johnson et al., 1,25-DIHYDROXYVITAMIN DG (1,25D(3)) AND PACLITAXEL - A NOVEL COMBINATION FOR THE TREATMENT OF SOLID TUMORS IN ANIMAL-MODEL SYSTEMS, Annals of oncology, 9, 1998, pp. 352-352
Authors:
JOHNSON CS
HERSHBERGER PA
MODZELEWSKI RA
TRUMP DL
Citation: Cs. Johnson et al., 1,25D(3) DIHYDROXYVITAMIN D-3 (1,25D(3)) AS AN ANTICANCER AGENT FOR PROSTATE-CANCER - PRECLINICAL STUDIES, The Journal of urology, 159(5), 1998, pp. 42-42
Authors:
MCELWAIN MC
MODZELEWSKI RA
YU WD
RUSSELL DM
JOHNSON CS
Citation: Mc. Mcelwain et al., VITAMIN-D - AN ANTIPROLIFERATIVE AGENT WITH POTENTIAL FOR THERAPY OF SQUAMOUS-CELL CARCINOMA, American journal of otolaryngology, 18(5), 1997, pp. 293-298
Authors:
CHANG MJ
MODZELEWSKI RA
RUSSELL DM
JOHNSON CS
Citation: Mj. Chang et al., INTERLEUKIN-1-ALPHA AND GAMMA-INTERFERON INDUCTION OF NITRIC-OXIDE PRODUCTION FROM MURINE TUMOR-DERIVED ENDOTHELIAL-CELLS, Cancer research, 56(4), 1996, pp. 886-891
Authors:
HOYT DG
RUSNAK JM
MANNIX RJ
MODZELEWSKI RA
JOHNSON CS
LAZO JS
Citation: Dg. Hoyt et al., INTEGRIN ACTIVATION SUPPRESSES ETOPOSIDE-INDUCED DNA STRAND BREAKAGE IN CULTURED MURINE TUMOR-DERIVED ENDOTHELIAL-CELLS, Cancer research, 56(18), 1996, pp. 4146-4149
Authors:
CHANG MJ
YU WD
REYNO LM
MODZELEWSKI RA
EGORIN MJ
ERKMEN K
VLOCK DR
FURMANSKI P
JOHNSON CS
Citation: Mj. Chang et al., POTENTIATION BY INTERLEUKIN-1-ALPHA OF CISPLATIN AND CARBOPLATIN ANTITUMOR-ACTIVITY - SCHEDULE-DEPENDENT AND PHARMACOKINETIC EFFECTS IN THERIF-1 TUMOR-MODEL, Cancer research, 54(20), 1994, pp. 5380-5386
Authors:
MODZELEWSKI RA
DAVIES P
WATKINS SC
AUERBACH R
CHANG MJ
JOHNSON CS
Citation: Ra. Modzelewski et al., ISOLATION AND IDENTIFICATION OF FRESH TUMOR-DERIVED ENDOTHELIAL-CELLSFROM A MURINE RIF-1 FIBROSARCOMA, Cancer research, 54(2), 1994, pp. 336-339
Authors:
JOHNSON CS
CHANG MJ
YU WD
MODZELEWSKI RA
GRANDIS JR
VLOCK DR
FURMANSKI P
Citation: Cs. Johnson et al., SYNERGISTIC ENHANCEMENT BY INTERLEUKIN-1-ALPHA OF CISPLATIN-MEDIATED ANTITUMOR-ACTIVITY IN RIF-1 TUMOR-BEARING C3H HEJ MICE/, Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 339-346